The share holdersLuisa Bracci, PhD
She is presently Full Professor of Biochemistry at the School of Medicine, University of Siena. She has a Biology degree and a PhD in Animal Biology. She possesses a prolonged experience in protein and peptide biochemistry. During her formation she spent some periods at Sclavo Research Center in Siena (1983-1985), at the Salk Institute for Biological Science in San Diego, USA (1985), and at the Institute de Biologie Moleculaire et Cellulaire, CNRS, Strasburg France (1992). From 1998 to 2000 she was member of the Executive Board of the University of Siena and in 2003 she was member.of the Executive Board of Philotec Srl. Form 2004 to 2009 she was member of the Executive Board of Siena Biotech Spa. Her scientific activity is documented by many publications and several patents in the field of biotech applications of peptide molecules. She is founder of SetLance and member of the Executive Board.
Chiara Falciani, PhD
She is presently Researcher at the University of Siena. She has a Pharmaceutical Chemistry degree and a PhD in Organic Chemistry. Part of her training was spent at the Institut für Organische und Biomolekulare Chemie di Göttingen in Germany. She has now a long-time experience in organic synthesis and molecular biology techniques and equipments. She has been in charge of the Biological Chemistry teaching at the School of Specialisation in Radiodiagnostics at the Faculty of Medicine, University of Siena. Since 2002, she is a freelance project leader and advisor of a private Biotech Company, for which she coordinated an EU project (FP6-STREP) in the area of Health, and Tuscany Regional Projects. Her scientific activity is documented by many publications and several patents in the field of chemistry and biochemistry. She is founder of SetLance and member of the Executive Board.
Alessandro Pini, PhD
He is presently Researcher at the University of Siena. He teaches Biochemistry and Molecular Biotechnology at the Course of Biotechnology of the same University. He possesses a PhD in Biotechnology and has a long experience in the field of combinatorial biology with a special focus on Phage Display technology. During his formation he spent some periods at the Centre for Protein Engineering of the Medical Research Council in Cambridge, UK (1995), and at the Federal Institute of Technology (ETH) in Zurich, Switzerland (1997). From 1999 to 2005 he was member of the Executive Board of Philotec Srl and scientific consultant of Philogen Spa. His scientific activity is documented by many publications and several patents in the field of antibody engineering and peptides. He is founder of SetLance and President of the Executive Board.
Eudax was established in 2005 with the primary objective of providing strategic support and services for drug development to biopharmaceuticals and biotech companies, and scientific institution. Eudax provides several services including:
- Chemical synthesis process optimization and formulation strategy development; pharmacology and toxicology for preclinical studies;
- Design and execution of phase I/II-III clinical trials; pharmacovigilance;
- Regulatory strategies and health authorities networking;
- Dossier preparation, submission and follow-up for clinical trial application;
- Business development activities.
Eudax has its main office in Milano and subsidiaries in Pavia and Siena.